CN103432475B - 一种治疗过敏性鼻炎的中药组合物及其制备方法 - Google Patents
一种治疗过敏性鼻炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103432475B CN103432475B CN201310404620.7A CN201310404620A CN103432475B CN 103432475 B CN103432475 B CN 103432475B CN 201310404620 A CN201310404620 A CN 201310404620A CN 103432475 B CN103432475 B CN 103432475B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 134
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 46
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 27
- 239000009636 Huang Qi Substances 0.000 claims abstract description 22
- 240000001812 Hyssopus officinalis Species 0.000 claims abstract description 13
- 235000010650 Hyssopus officinalis Nutrition 0.000 claims abstract description 13
- 238000011282 treatment Methods 0.000 claims description 66
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 48
- 201000010099 disease Diseases 0.000 claims description 42
- 229940079593 drug Drugs 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 241000628997 Flos Species 0.000 claims description 22
- 210000000582 semen Anatomy 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 239000007923 nasal drop Substances 0.000 claims description 16
- 239000000341 volatile oil Substances 0.000 claims description 15
- 241001643642 Viticis Species 0.000 claims description 12
- 239000009670 cang er zi wan Substances 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 10
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 238000000703 high-speed centrifugation Methods 0.000 claims description 2
- 238000001256 steam distillation Methods 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 abstract description 62
- 230000000694 effects Effects 0.000 abstract description 35
- 210000000952 spleen Anatomy 0.000 abstract description 32
- 230000008901 benefit Effects 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract description 10
- 230000002588 toxic effect Effects 0.000 abstract description 10
- 238000005728 strengthening Methods 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 241001521901 Tribulus lanuginosus Species 0.000 abstract description 2
- 235000001667 Vitex agnus castus Nutrition 0.000 abstract description 2
- 244000063464 Vitex agnus-castus Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000931705 Cicada Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 240000001090 Papaver somniferum Species 0.000 abstract 1
- 235000008753 Papaver somniferum Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 241001626023 Syringa pubescens subsp. patula Species 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 241001561579 Ziziphora clinopodioides Species 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 43
- 230000036407 pain Effects 0.000 description 40
- 210000001331 nose Anatomy 0.000 description 31
- 230000007812 deficiency Effects 0.000 description 28
- 210000003734 kidney Anatomy 0.000 description 28
- 230000001717 pathogenic effect Effects 0.000 description 28
- 208000024891 symptom Diseases 0.000 description 24
- 238000012360 testing method Methods 0.000 description 23
- 206010019233 Headaches Diseases 0.000 description 22
- 231100000869 headache Toxicity 0.000 description 21
- 206010011224 Cough Diseases 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 18
- 208000026435 phlegm Diseases 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 241000411851 herbal medicine Species 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 17
- 210000003128 head Anatomy 0.000 description 16
- 244000052769 pathogen Species 0.000 description 16
- 208000003251 Pruritus Diseases 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 230000008961 swelling Effects 0.000 description 15
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 14
- 206010030113 Oedema Diseases 0.000 description 14
- 208000006820 Arthralgia Diseases 0.000 description 13
- 206010047700 Vomiting Diseases 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 12
- 208000001848 dysentery Diseases 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 206010039101 Rhinorrhoea Diseases 0.000 description 11
- 208000033809 Suppuration Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 208000011580 syndromic disease Diseases 0.000 description 11
- 230000008673 vomiting Effects 0.000 description 11
- 201000004624 Dermatitis Diseases 0.000 description 10
- 206010028748 Nasal obstruction Diseases 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 239000013566 allergen Substances 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 239000002398 materia medica Substances 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 239000006187 pill Substances 0.000 description 9
- 201000005404 rubella Diseases 0.000 description 9
- 201000009890 sinusitis Diseases 0.000 description 9
- 210000001835 viscera Anatomy 0.000 description 9
- 206010010726 Conjunctival oedema Diseases 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 8
- 208000010668 atopic eczema Diseases 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000003172 expectorant agent Substances 0.000 description 8
- 230000003419 expectorant effect Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 206010042674 Swelling Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 230000036528 appetite Effects 0.000 description 7
- 235000019789 appetite Nutrition 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 208000010753 nasal discharge Diseases 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010040943 Skin Ulcer Diseases 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000003026 hypopharynx Anatomy 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 231100000019 skin ulcer Toxicity 0.000 description 6
- 230000035943 smell Effects 0.000 description 6
- 206010041232 sneezing Diseases 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 241000256844 Apis mellifera Species 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 201000005505 Measles Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000001139 anti-pruritic effect Effects 0.000 description 5
- 239000003908 antipruritic agent Substances 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000006735 deficit Effects 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 206010013952 Dysphonia Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 208000010473 Hoarseness Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010067171 Regurgitation Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 201000003453 lung abscess Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000002850 nasal mucosa Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001387 anti-histamine Effects 0.000 description 3
- 239000000739 antihistaminic agent Substances 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000001314 paroxysmal effect Effects 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 240000004528 Catalpa ovata Species 0.000 description 2
- 235000010005 Catalpa ovata Nutrition 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 108090000978 Interleukin-4 Proteins 0.000 description 2
- 108010002616 Interleukin-5 Proteins 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000002740 Muscle Rigidity Diseases 0.000 description 2
- 206010028720 Nasal abscess Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000576855 Syringa reticulata Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000027993 eye symptom Diseases 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000008945 zhigancao decoction Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 201000002045 Ancylostomiasis Diseases 0.000 description 1
- 208000033211 Ankylostomiasis Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000397426 Centroberyx lineatus Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000338702 Cupido minimus Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020376 Hookworm infection Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 108010025252 Kassinin Chemical class 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001522232 Pinellia ternata Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001282135 Poromitra oscitans Species 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 206010037569 Purulent discharge Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 241001104043 Syringa Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010043994 Tonic convulsion Diseases 0.000 description 1
- 208000013222 Toxemia Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002590 anti-leukotriene effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000012154 short term therapy Methods 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- -1 sublimed preparation Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310404620.7A CN103432475B (zh) | 2013-09-06 | 2013-09-06 | 一种治疗过敏性鼻炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310404620.7A CN103432475B (zh) | 2013-09-06 | 2013-09-06 | 一种治疗过敏性鼻炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103432475A CN103432475A (zh) | 2013-12-11 |
CN103432475B true CN103432475B (zh) | 2015-03-25 |
Family
ID=49686259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310404620.7A Expired - Fee Related CN103432475B (zh) | 2013-09-06 | 2013-09-06 | 一种治疗过敏性鼻炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103432475B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137519A (zh) * | 2017-04-18 | 2017-09-08 | 张世卿 | 一种治疗鼻炎的中药栓剂及其制备方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105596571A (zh) * | 2013-12-30 | 2016-05-25 | 青岛华之草医药科技有限公司 | 一种制备治疗过敏性鼻炎的中药组合物颗粒剂的方法 |
CN104524297A (zh) * | 2015-01-06 | 2015-04-22 | 张玉英 | 一种治疗肾阳不足型变应性鼻炎的中药 |
CN104491559A (zh) * | 2015-01-15 | 2015-04-08 | 王瑞红 | 一种治疗脾气虚弱型变应性鼻炎的中药 |
CN106310008A (zh) * | 2016-05-03 | 2017-01-11 | 张道华 | 一种治疗过敏性鼻炎的中药组合物及制备方法 |
CN105943940A (zh) * | 2016-07-20 | 2016-09-21 | 孙丰卿 | 一种用于治疗过敏性鼻炎的中药组合物及其制剂的制备方法 |
CN108531097A (zh) * | 2018-05-29 | 2018-09-14 | 惠州市浩明科技股份有限公司 | 皮肤抗过敏胶粘材料及其制备方法 |
CN116870112B (zh) * | 2023-08-28 | 2024-04-19 | 山西医科大学第一医院 | 一种治疗变应性鼻炎的中药制剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101259242A (zh) * | 2008-04-17 | 2008-09-10 | 赵开峰 | 一种治疗过敏性鼻炎的药物 |
-
2013
- 2013-09-06 CN CN201310404620.7A patent/CN103432475B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101259242A (zh) * | 2008-04-17 | 2008-09-10 | 赵开峰 | 一种治疗过敏性鼻炎的药物 |
Non-Patent Citations (1)
Title |
---|
中草药治疗过敏性鼻炎概况;范愈燕;《中医临床研究》;20130131;第5卷(第1期);21-22页 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137519A (zh) * | 2017-04-18 | 2017-09-08 | 张世卿 | 一种治疗鼻炎的中药栓剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103432475A (zh) | 2013-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN103520578B (zh) | 一种治疗口腔溃疡的中药组合物及其制备方法 | |
CN102048933A (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN104367879A (zh) | 一种用于治疗鸡劳伤的药物组合物及其制备方法 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN103638250B (zh) | 一种治疗面神经麻痹的中药制剂及其制备方法 | |
CN104147552A (zh) | 一种治疗血瘀型产后腹痛的中药组合物及其制备方法 | |
CN103520655A (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
CN107596197A (zh) | 一种补气解郁茶及其制备方法 | |
CN103417886B (zh) | 一种治疗支气管哮喘的中药组合物及其制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN102178781A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
CN105106916A (zh) | 一种产后护理用中药 | |
CN104840872A (zh) | 一种治疗冠心病稳定型心绞痛合并糖尿病高脂血症的中药 | |
CN104689283A (zh) | 一种治疗脾虚湿蕴型黄褐斑的药物及其制备方法 | |
CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
CN110538288A (zh) | 一种调理体质和防治疾病的智能系统贴膏及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN116350704B (zh) | 一种治疗继发性癫痫的中药组合物及其制备方法 | |
CN106177736A (zh) | 一种缓解肠胃不适引起便秘的艾叶保健茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHONGXIN HOSPITAL, QINGDAO Free format text: FORMER OWNER: LIANG YIPENG Effective date: 20150202 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Aihong Inventor after: Mei Hong Inventor after: Xu Hua Inventor before: Liang Yipi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 266000 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIANG YIPENG TO: XU AIHONG MEI HONG XU HUA |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150202 Address after: 266000 No. four, No. 127 South Road, Shandong, Qingdao Applicant after: QINGDAO CENTRAL Hospital Address before: 250000 Shandong City, Ji'nan, No. ten via road 4, building 4, unit 25156, 402 Applicant before: Liang Yipi |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180607 Address after: 330114 10, 1, Xiong Jia village, Xinjian County, Nanchang, Jiangxi Patentee after: Liu Yanfang Address before: No. 127, four - flow South Road, Qingdao, Shandong Province Patentee before: QINGDAO CENTRAL Hospital |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181016 Address after: 331200 Chengbei Industrial Park, Zhangshu City, Jiangxi Patentee after: Jiangxi Zhi Entang traditional Chinese medicines Science and Technology Ltd. Address before: 330114 10, 1, Xiong Jia village, Xinjian County, Nanchang, Jiangxi Patentee before: Liu Yanfang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200508 Address after: 063000 North Street, Wenzhou Commercial City, Kaiping District, Tangshan City, Hebei Province, 26 Patentee after: TANGSHAN XINYANUO BIOTECHNOLOGY Co.,Ltd. Address before: 331200 Chengbei Industrial Zone, Zhangshu City, Jiangxi Province Patentee before: Jiangxi Zhi Entang traditional Chinese medicines Science and Technology Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230421 Address after: 063021 1st Floor, East Side of Chengxi Road, Kaiping District, Tangshan City, Hebei Province Patentee after: Tangshan Muheyuan Technology Co.,Ltd. Address before: 063000 No.26, North Street, Wenzhou mall, Kaiping District, Tangshan City, Hebei Province Patentee before: TANGSHAN XINYANUO BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150325 |